# Testing of Glycerin, Propylene Glycol, Maltitol Solution, Hydrogenated Starch Hydrolysate, Sorbitol Solution, and Other High-Risk Drug Components for Diethylene Glycol and Ethylene Glycol - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/testing-of-glycerin-propylene-glycol-maltitol-solution-hydrogenated-starch-hydrolysate-sorbitol-solution-and-other-high-risk-drug-components-for-diethylene-glycol-and-ethylene-glycol/c8a74c49-b384-48bc-ae23-67d70dd41b1d

> FDA guidance document: Testing of Glycerin, Propylene Glycol, Maltitol Solution, Hydrogenated Starch Hydrolysate, Sorbitol Solution, and Other High-Risk Drug Components for Diethylene Glycol and Ethylene Glycol. Issue date: May 08, 2023. Get complete insights and analysis.

---

## Details

- Title: Testing of Glycerin, Propylene Glycol, Maltitol Solution, Hydrogenated Starch Hydrolysate, Sorbitol Solution, and Other High-Risk Drug Components for Diethylene Glycol and Ethylene Glycol
- Communication Type: Guidance Document
- Product Type: other
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2023-05-08
- Last Changed: 2023-07-10
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2023-D-1573 ">FDA-2023-D-1573 </a>

## Related Documents

- [Temporary Policies for Compounding Certain Parenteral Drug Products:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/temporary-policies-for-compounding-certain-parenteral-drug-products-guidance-for-industry/46ee42bb-92f0-47bf-a6e8-2980ea59392a)
- [Policy for Testing of Alcohol (Ethanol) and Isopropyl Alcohol for Methanol:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/policy-for-testing-of-alcohol-ethanol-and-isopropyl-alcohol-for-methanol-guidance-for-industry/a25ea3c0-e08b-4e4a-a585-a8d8648fe2a6)
- [Compounding Certain Ibuprofen Oral Suspension Products Under Section 503B of the Federal Food, Drug, and Cosmetic Act](https://www.globalkeysolutions.net/guidances/guidance-document/compounding-certain-ibuprofen-oral-suspension-products-under-section-503b-of-the-federal-food-drug-and-cosmetic-act/42ece20e-b981-40c7-8486-325a2b13d7dc)